Hervé Eloi Dominique Brailly
Vorstandsvorsitzender bei INNATE PHARMA
Vermögen: 2 Mio $ am 30.04.2024
Profil
Hervé Eloi Dominique Brailly is the founder of MI-MAbs SAS (2020), Innate Pharma SA (1999), Kalsiom SAS (2020), and Systol Dynamics SA (2019).
He is also the founder of Asajes Ventures Ltd.
Currently, Dr. Brailly holds the position of Chairman at Université d'Aix-Marseille, Chairman at Polytech Marseille, Chairman at Kervrant Biotech (since 2017), Chairman at NH TherAguix SAS (since 2019), Independent Director at Deinove SA, Director at Swenson Global SA, Treasurer at BioCuster, and Treasurer at EuroBioMed (since 2006).
In the past, he has worked as Director at France Biotech Association (2006-2008), Director at Innate Pharma, Inc., Member-Supervisory Board at INSERM Transfert SA, Member-Development Council at Marseille Provence Métropole, Member at Chambre de Commerce et d'Industrie Marseille Provence (2012), and Member-Executive Board at Platine Pharma Services SAS.
Dr. Brailly completed his undergraduate degree at École Nationale Supérieure des Mines de Paris in 1983.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
INNATE PHARMA SA CLASS A
0,91% | 31.12.2022 | 739 784 ( 0,91% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Hervé Eloi Dominique Brailly
Unternehmen | Position | Beginn |
---|---|---|
INNATE PHARMA | Vorstandsvorsitzender | 01.01.2024 |
DEINOVE | Direktor/Vorstandsmitglied | 16.05.2017 |
NH THERAGUIX SAS | Vorsitzender | 22.02.2019 |
Kervrant Biotech
Kervrant Biotech Financial ConglomeratesFinance Kervrant Biotech provides investment services. The private company is based in Primelin, France. | Vorsitzender | 22.02.2017 |
Systol Dynamics SA | Vorstandsvorsitzender | 31.10.2019 |
Kalsiom SAS
Kalsiom SAS Pharmaceuticals: MajorHealth Technology Kalsiom SAS develops inflammatory auto-immunity disorders antibody therapy. The company was founded by Hervé Eloi Dominique Brailly and Olivier Mignen on April 20, 2020 and is headquartered in Brest, France. | Vorstandsvorsitzender | - |
Université d'Aix-Marseille | Vorsitzender | - |
Asajes Ventures Ltd. | Gründer | - |
Swenson Global SA
Swenson Global SA Information Technology ServicesTechnology Services Swenson Global SA provides computer programming services. The private company is based in Audierne, France. | Direktor/Vorstandsmitglied | - |
░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Hervé Eloi Dominique Brailly
Unternehmen | Position | Ende |
---|---|---|
░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░ | ░░░░░░░░ | - |
Ausbildung von Hervé Eloi Dominique Brailly
École Nationale Supérieure des Mines de Paris | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INNATE PHARMA | Health Technology |
Private Unternehmen | 16 |
---|---|
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | Finance |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Deinove SA
Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Marseille Provence Métropole | Government |
EuroBioMed
EuroBioMed Miscellaneous Commercial ServicesCommercial Services EuroBioMed engages as an association related to healthcare research, engineering innovation and support for companies and projects. It operates in the following business segments: teaching, fundamental, translational and clinical research, technological innovation centers, start-ups and, industrial success stories. The company was founded in 2009 and is headquartered in Marseille, France. | Commercial Services |
Chambre de Commerce et d'Industrie Marseille Provence
Chambre de Commerce et d'Industrie Marseille Provence Other TransportationTransportation Chambre de Commerce et d'' Industrie Marseille Provence engages in the provision of financial information and trainings for business development. The company was founded on March 1, 1983 and is headquartered in Marseille, France. | Transportation |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Health Services |
Innate Pharma, Inc. | |
Kervrant Biotech
Kervrant Biotech Financial ConglomeratesFinance Kervrant Biotech provides investment services. The private company is based in Primelin, France. | Finance |
Swenson Global SA
Swenson Global SA Information Technology ServicesTechnology Services Swenson Global SA provides computer programming services. The private company is based in Audierne, France. | Technology Services |
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
Asajes Ventures Ltd. | |
Kalsiom SAS
Kalsiom SAS Pharmaceuticals: MajorHealth Technology Kalsiom SAS develops inflammatory auto-immunity disorders antibody therapy. The company was founded by Hervé Eloi Dominique Brailly and Olivier Mignen on April 20, 2020 and is headquartered in Brest, France. | Health Technology |
Systol Dynamics SA | |
MI-MAbs SAS
MI-MAbs SAS Miscellaneous Commercial ServicesCommercial Services MI-MAbs SAS is a French company that specializes in antibody engineering, biochemistry, bioproduction, and immunopharmacology. The private company is based in Marseille, France, and is located in the historical birthplace of Marseille Immunopôle. MI-MAbs has a fully integrated suite of platforms covering all steps leading to preclinical proof-of-concept. The company has established strategic scientific and technological partnerships with academia and industry, notably with CIPHE (transgenic mouse model engineering and immunomonitoring). The company was founded by Hervé Eloi Dominique Brailly in December 2020 through the acquisition of the assets of the demonstrator of immunotherapy mi-mabs, which was founded in 2011 as an academic laboratory of Aix-Marseille University. | Commercial Services |
BioCuster |